JAK inhibitors in rheumatoid arthritis-associated interstitial lung disease: a review of mechanisms and clinical evidence.

Front Immunol · 2026 · PMC13368870 · PMID 42459674

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Furthermore, this review highlighted that methotrexate (MTX) and abatacept (ABA) were associated with a reduced risk of disease progression and mortality, while tumor necrosis factor inhibitors (TNFi) showed a trend toward increased progression risk ( 1 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.